Article thumbnail

Characterization of Serum Proteins Associated with IL28B Genotype among Patients with Chronic Hepatitis C

By Derek D. Cyr, Joseph E. Lucas, J. Will Thompson, Keyur Patel, Paul J. Clark, Alexander Thompson, Hans L. Tillmann, John G. McHutchison, M. Arthur Moseley and Jeanette J. McCarthy
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2008). A genome-wide association study identifies protein quantitative trait loci (pQTLs).
  2. (1999). Allelic discrimination using fluorogenic probes and the 59 nuclease assay.
  3. (2008). Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset.
  4. (1998). Change of peripheral levels of pituitary hormones and cytokines after injection of interferon (IFN)-beta in patients with chronic hepatitis C.
  5. (2010). Corticosteroid-binding globulin: the clinical significance of altered levels and heritable mutations.
  6. (2002). Cortisol-binding globulin is important in the interpretation of dynamic tests of the hypothalamic–pituitary–adrenal axis.
  7. (1995). Differential effects of insulin and insulin-like growth factor I on the production of plasma steroidbinding globulins by human hepatoblastoma-derived (Hep G2) cells.
  8. (2007). Genetic basis of proteome variation in yeast.
  9. (2009). Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.
  10. (2010). Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.
  11. (2009). Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.
  12. (2009). Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.
  13. (2010). Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.
  14. (2005). Hepatitis C and liver transplantation.
  15. (2011). High predictive accuracy of an unbiased proteomic profile to predict sustained virologic response in genotype 1 chronic hepatitis C patients. Hepatology.
  16. (2010). IL28B genotype is associated with differential expression of intrahepatic interferonstimulated genes in patients with chronic hepatitis C.
  17. (2009). IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.
  18. (2005). Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.
  19. (2008). Interferon signaling and treatment outcome in chronic hepatitis C.
  20. (2010). Interferon-a effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior.
  21. (2011). Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.
  22. (1999). Plasma total and glycosylated corticosteroid-binding globulin levels are associated with insulin secretion.
  23. (2010). Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin.
  24. (2002). Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study.
  25. (2009). Serum total cortisol and free cortisol index give different information regarding the hypothalamus-pituitary-adrenal axis reserve in patients with liver impairment.
  26. (2004). The Global Burden of Hepatitis C Working Group